Says several important clinical trials slated for 2H26. “Confident” in acceleration of growth in 2H26. Comments taken from Q1 earnings conference call.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Abbott reports Q1 adjusted EPS $1.15, consensus $1.15
- Abbott cuts FY26 adjusted EPS view to $5.38-$5.58 from $5.55-$5.80
- Abbott sees Q2 adjusted EPS $1.25-$1.31, consensus $1.32
- Options Volatility and Implied Earnings Moves Today, April 16, 2026
- These Are the Stocks Reporting Earnings Today – April 16, 2026